Literature DB >> 15269321

New treatment options for colorectal cancer.

Charles Erlichman, Daniel J Sargent.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15269321     DOI: 10.1056/NEJMe048151

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Natural products as leads to anticancer drugs.

Authors:  M Gordaliza
Journal:  Clin Transl Oncol       Date:  2007-12       Impact factor: 3.405

2.  Immunohistochemical detection of receptor tyrosine kinases c-kit, EGF-R, and PDGF-R in colorectal adenocarcinomas.

Authors:  Jan Friederichs; Claus W H von Weyhern; Robert Rosenberg; Dietrich Doll; Raymonde Busch; Florian Lordick; Jörg Rüdiger Siewert; Mario Sarbia
Journal:  Langenbecks Arch Surg       Date:  2009-03-12       Impact factor: 3.445

Review 3.  Cost considerations in the treatment of colorectal cancer.

Authors:  Frank G A Jansman; Maarten J Postma; Jacobus R B J Brouwers
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

4.  Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy--a case report.

Authors:  Valeria Milani; Stefan Stangl; Rolf Issels; Mathias Gehrmann; Beate Wagner; Kathrin Hube; Doris Mayr; Wolfgang Hiddemann; Michael Molls; Gabriele Multhoff
Journal:  J Transl Med       Date:  2009-06-23       Impact factor: 5.531

Review 5.  The role of epidermal growth factor receptor in cancer metastasis and microenvironment.

Authors:  Takamitsu Sasaki; Kuniyasu Hiroki; Yuichi Yamashita
Journal:  Biomed Res Int       Date:  2013-08-07       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.